Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

Abstract Individualising biologic disease-modifying anti-rheumatic drugs (bDMARDs) to maximise outcomes and deliver safe and cost-effective care is a key goal in the management of rheumatoid arthritis (RA). Investigation to identify predictive tools of bDMARD response is a highly active and prolific...

Full description

Bibliographic Details
Main Authors: Vasco C. Romão, Edward M. Vital, João Eurico Fonseca, Maya H. Buch
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Arthritis Research & Therapy
Subjects:
Personalised therapy
Biological therapy
Rheumatoid arthritis
Response predictors
Biomarkers
Online Access:http://link.springer.com/article/10.1186/s13075-017-1445-3

Internet

http://link.springer.com/article/10.1186/s13075-017-1445-3

Similar Items